All In Biotech

Drug Trial Radar · NCT07158814

Safety of RSV Preventive Monoclonal Antibody

Safety of Simultaneous Administration of Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody With Routine Childhood Immunizations in Infants

Last checked: Nov 20, 2026Latest source record: Mar 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 524 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

524

Planned (sponsor's estimate)

Start

Oct 2, 2025

Primary completion

Feb 2027

Study completion Apr 2027

Sponsor

Lead sponsor
Duke UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Centers for Disease Control and Prevention; Children's Hospital Medical Center, Cincinnati; Columbia University; Emory University; Kaiser Permanente
First posted
Sep 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 6 weeks, up to 30 weeks
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a prospective, randomized, open-label clinical trial to evaluate the safety of administration of respiratory syncytial virus (RSV) preventive monoclonal antibody and other routine childhood vaccines given simultaneously at Visit 1, as compared to sequential administration of respiratory syncytial virus (RSV) preventive monoclonal antibody and other vaccines at separate visits (Visits 1 and 2).

Conditions

  • Fever
  • Adverse Event Following Immunisation

Interventions

  • Respiratory Syncytial Virus (RSV) Preventive Monoclonal AntibodyDrug

    ACIP Recommended Preventive Monoclonal Antibody

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Fever Following ImmunizationTime frame: Up to 2 days post administration

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Kaiser Permanente Northern California

    Oakland, California · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Centers for Disease Control and Prevention

    Atlanta, Georgia · Active not recruiting

  • Columbia University

    New York, New York · Recruiting

  • Duke University

    Durham, North Carolina · Recruiting

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.